Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | +14.07% | +16.73% | +5.63% |
Evolution of the average Target Price on DiaMedica Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering DiaMedica Therapeutics Inc.
Oppenheimer | |
Craig-Hallum | |
Lake Street | |
Roth Capital Partners | |
Maxim |
EPS Revisions
- Stock Market
- Equities
- DMAC Stock
- Consensus DiaMedica Therapeutics Inc.